Hiddemann W - Search Results

1

Increase of P-glycoprotein-mediated drug resistance by hsp 90 beta.

Bertram J, Palfner K, Hiddemann W, Kneba M. Bertram J, et al. Among authors: hiddemann w. Anticancer Drugs. 1996 Nov;7(8):838-45. doi: 10.1097/00001813-199611000-00004. Anticancer Drugs. 1996. PMID: 8991187

2

Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression.

Bertram J, Palfner K, Hiddemann W, Kneba M. Bertram J, et al. Among authors: hiddemann w. Anticancer Drugs. 1998 Apr;9(4):311-7. doi: 10.1097/00001813-199804000-00004. Anticancer Drugs. 1998. PMID: 9635921

3

Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes.

Bertram J, Palfner K, Killian M, Brysch W, Schlingensiepen KH, Hiddemann W, Kneba M. Bertram J, et al. Among authors: hiddemann w. Anticancer Drugs. 1995 Feb;6(1):124-34. doi: 10.1097/00001813-199502000-00015. Anticancer Drugs. 1995. PMID: 7756675

4

Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR.

Bertram J, Palfner K, Hiddemann W, Kneba M. Bertram J, et al. Among authors: hiddemann w. Eur J Cancer. 1998 Apr;34(5):731-6. doi: 10.1016/s0959-8049(97)10081-8. Eur J Cancer. 1998. PMID: 9713282

5

Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.

Palfner K, Kneba M, Hiddemann W, Bertram J. Palfner K, et al. Among authors: hiddemann w. Biol Chem Hoppe Seyler. 1995 May;376(5):289-95. doi: 10.1515/bchm3.1995.376.5.289. Biol Chem Hoppe Seyler. 1995. PMID: 7544982

6

Short technical reports. Quantification of ribozyme-mediated RNA cleavage using silver-stained polyacrylamide gels.

Palfner K, Kneba M, Hiddemann W, Bertram J. Palfner K, et al. Among authors: hiddemann w. Biotechniques. 1995 Dec;19(6):926-9. Biotechniques. 1995. PMID: 8747658

7

Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin.

Beyer-Sehlmeyer G, Hiddemann W, Wörmann B, Bertram J. Beyer-Sehlmeyer G, et al. Among authors: hiddemann w. Eur J Cancer. 1999 Nov;35(12):1735-42. doi: 10.1016/s0959-8049(99)00202-6. Eur J Cancer. 1999. PMID: 10674022

8

Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis.

Kneba M, Bolz I, Linke B, Hiddemann W. Kneba M, et al. Among authors: hiddemann w. Blood. 1995 Nov 15;86(10):3930-7. Blood. 1995. PMID: 7579363 Free article.

9

Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing.

Kneba M, Bolz I, Linke B, Bertram J, Rothaupt D, Hiddemann W. Kneba M, et al. Among authors: hiddemann w. Blood. 1994 Jul 15;84(2):574-81. Blood. 1994. PMID: 8025283 Free article.

10

Low incidence of mbr bcl-2/JH fusion genes in Hodgkin's disease.

Kneba M, Eick S, Herbst H, Pott C, Bolz I, Dallenbach F, Hiddemann W, Stein H. Kneba M, et al. Among authors: hiddemann w. J Pathol. 1995 Apr;175(4):381-9. doi: 10.1002/path.1711750404. J Pathol. 1995. PMID: 7790991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

913 results

Search Page